OptimizeRx Corporation (OPRX) Q2 FY26 Earnings Call

Guidance held despite lower revenue, while margin expansion, debt reduction, and programmatic growth offset customer concentration and macro risks [1][2][17][26].

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-12
Length43 minutes
EPS$0.08
Revenue$19.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All OPRX earnings ยท Back to OPRX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.